Among the known molecules, betulinic
amide (3) was earlier reported as a semi-synthetic product. The structures of new molecules 1, 2 and 4 were elucidated on the basis of extensive spectroscopic investigations (1D NMR, 2D NMR and mass spectrometry).”
“CdS nanocomposites have been grown in polyvinyl alcohol matrix by a chemical synthesis process. The transmission electron Selleckchem GSK3326595 micrographs of nanocomposites synthesized at 70-90 degrees C temperature showed the growth of needlelike and junctionlike nanostructures. X-ray photoelectron spectroscopy analysis revealed the growth of stoichiometric CdS without the formation of any intermediate phases at the CdS-polyvinyl alcohol interface. Raman spectra of first order longitudinal optical phonon peak has been analyzed using phonon dispersion model to detect the surface phonon modes in CdS nanoneedles and wires. The origin of negative differential resistance behavior in current-voltage characteristics JNJ-26481585 order for junctionlike CdS nanocomposites has been discussed.”
“Purpose: The benefits of utilizing computerized assessment in clinical settings have been reported in
studies over the last three decades and more recently in the oncology settings. This study aimed to assess the feasibility and acceptability of using an electronic self report symptom assessment tool among Chinese oncology patients.
Methods and sample: The tool, developed by The University of Washington, Distributed Health Assessment and Intervention Research (DHAIR) group was translated into Chinese. The adapted web-based survey platform, the Electronic Self Report Assessment – Cancer (ESRA-C), was tested in a local cancer resource center in Hong Kong. Participants’ perceptions of the acceptability and feasibility of the symptom assessment process were assessed using the Acceptability E-scale as well as observation and qualitative interview data. Demographic data were also collected through the touch screen computer system.
A convenience sample of 30 (11 male and 19 female) oncology patients was recruited to use the touch-screen computer to assess participants’ symptoms using ESRA-C.
Results: The acceptability scale indicated moderately MEK phosphorylation high acceptability in each subscale (mean score of 3.32-4.71). On average, participants took 17.5 min (SD: 8.9) to complete the ESRA-C. The qualitative interview data revealed that the majority (25 participants) asserted that the ESRA-C was useful and effective in reporting personal health conditions.
Conclusions: The study suggested that electronic assessment can offer a feasible, attractive, and viable means of implementing regular and comprehensive symptom assessment, which can lead to better symptom management in cancer patients. (C) 2010 Elsevier Ltd.